EUCTR2006-006184-23-SKActive, not recruitingPhase 1
A randomised, double-blind, placebo- and olanzapine- controlled, parallel-group study to evaluate the efficacy and safety of 3 fixed doses of S 33138 in treatment of patients with an acute episode of Schizophrenia. A phase IIb, international, multicentre, 8-week study
Institut de Recherches Internationales Servier0 sites0 target enrollmentStarted: April 18, 2008Last updated:
Conditions
Drugs
Trial Snapshot
- Phase
- Phase 1
- Status
- Active, not recruiting
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional clinical trial of medicinal product
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •Inpatients between 18 and 50 years of age (included), male or female, hospitalised for an acute episode of schizophrenia (relapse or recurrence).
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) no
- •F.1.3.1 Number of subjects for this age range
Exclusion Criteria
- •Patient presenting a first episode of schizophrenia.
- •Women of childbearing potential or women who have been post menopausal for less than 2 years without effective contraception (implants, injectables, combined oral contraceptive method, intra-uterine devices, sexual abstinence or vasectomised partner) as well as pregnant or breastfeeding women.
Investigators
Similar Trials
Active, not recruiting
Not Applicable
A randomised, double-blind, placebo controlled, parallel group, multicentre two week study to evaluate the efficacy and safety of once-daily, intranasal administration of GW685698X aquenous nasal spray 100mcg in adult and adolescent subjects with seasonal allergic rhinitis in EuropeSeasonal allergic rhinitisEUCTR2004-004434-14-LVGlaxoSmithKline Research & Development Limited288
Active, not recruiting
Phase 1
A Phase II Study to evaluate efficacy, safety, tolerability and pharmacokinetics of ONO-4474 in patients with pain due to osteoarthritis of the kneeOsteoarthritic PainMedDRA version: 20.0Level: LLTClassification code 10073925Term: Generalised osteoarthritisSystem Organ Class: 100000004859EUCTR2016-002675-97-PLOno Pharmaceutical Co., Ltd.280
Active, not recruiting
Phase 1
A clinical trial in adults with newly diagnosed type 1 diabetes mellitus investigating the effect of Verapamil SR on the preservation of beta-cell functioType 1 diabetes mellitus(T1DM)MedDRA version: 21.1Level: PTClassification code 10067584Term: Type 1 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2020-000435-45-ITMedical University of Graz120
Active, not recruiting
Phase 1
A Phase II Study to evaluate efficacy, safety, tolerability and pharmacokinetics of ONO-4474 in patients with pain due to osteoarthritis of the kneeOsteoarthritic PainMedDRA version: 20.0Level: LLTClassification code 10073925Term: Generalised osteoarthritisSystem Organ Class: 100000004859EUCTR2016-002675-97-DKOno Pharmaceutical Co., Ltd.280
Active, not recruiting
Phase 1
A clinical trial in adults with newly diagnosed type 1 diabetes mellitus investigating the effect of Verapamil SR on the preservation of beta-cell functioType 1 diabetes mellitus(T1DM)MedDRA version: 21.1Level: PTClassification code 10067584Term: Type 1 diabetes mellitusSystem Organ Class: 10027433 - Metabolism and nutrition disordersEUCTR2020-000435-45-DEMedical University of Graz120